Sharegolders of South African pharmaceutical company Cipla Medpro on Wednesday approved the acquisition of its entire issued capital by Indian pharmaceutical group Cipla, in a deal valued at R4.5bn.
The deal, one of the single biggest foreign direct investments into South Africa to date, aims to strengthen Cipla Medpro’s position in the South African market, expand its manufacturing facility in Durban and support its expansion into Africa.